Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis - Related Studies

Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis

This study is ongoing, but not recruiting participants.

Study NCT00004686. Last updated on June 23, 2005. Information provided by FDA Office of Orphan Products Development

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Giant Cell Arteritis

2	Additional conditions recognized in this trial
		Arteritis
		Polymyalgia Rheumatica

3	More general conditions related to this trial
		Autoimmune Diseases
		Autoimmune Diseases of the Nervous System
		Brain Diseases
		Cardiovascular Diseases
		Central Nervous System Diseases
		Cerebrovascular Disorders
		Connective Tissue Diseases
		Immune System Diseases
		Muscular Diseases
		Musculoskeletal Diseases
		Nervous System Diseases
		Rheumatic Diseases
		Skin Diseases
		Skin Diseases, Vascular
		Vascular Diseases
		Vasculitis
		Vasculitis, Central Nervous System

4	Interventions listed in this trial
		methotrexate
		prednisone

5	More general drug interventions related to this trial
		Abortifacient Agents
		Abortifacient Agents, Nonsteroidal
		Anti-Inflammatory Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Antirheumatic Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		FDA Office of Orphan Products Development
		The Cleveland Clinic